Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jonathan Godin

Orthopaedic Surgery Vail, CO Medical Doctor

NPI 1376833251 CMS profile 1941384

181 W Meadow Dr Ste 400, Vail, CO 81657

Open in the dashboard

General payments

$101,904

137 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$75,000

3 holdings reported · through program year 2025

Research they led as principal investigator

$264,900 paid to institutions, not to them · program years 2021–2025

Through program year 2025, Jonathan Godin of Vail, CO is reported in the CMS Open Payments database as having received $101,904 across 137 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $264,900 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $75,000 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,682 19
2024 General $12,028 17
2023 General $3,369 15
2022 General $28,744 25
2021 General $10,594 13
2020 General $4,261 11
2019 General $19,225 37
2025 Ownership $25,000 1
2024 Ownership $25,000 1
2023 Ownership $25,000 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jonathan Godin
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Jonathan Godin were reported at $23,682. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Jonathan Godin Orthopaedic Surgery median Middle half National median
2019 $19,225 $644 $140–$2,844 $163
2020 $4,261 $312 $75–$1,860 $114
2021 $10,594 $520 $117–$2,495 $132
2022 $28,744 $598 $128–$2,731 $149
2023 $3,369 $461 $128–$2,264 $160
2024 $12,028 $497 $134–$2,475 $164
2025 $23,682 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $37,844 47 payments
  2. Bioventus LLC $33,202 34 payments
  3. Smith+Nephew, Inc. $21,799 21 payments
  4. DePuy Synthes Products, Inc. $4,680 3 payments
  5. Arthrex, Inc. $1,476 7 payments
  6. Gemini Mountain Medical, LLC $1,305 2 payments
  7. Medical Device Business Services, Inc. $1,121 7 payments
  8. DePuy Synthes Sales Inc. $301 9 payments
  9. Vericel Corporation $79 3 payments
  10. Vertex Pharmaceuticals Incorporated $31 1 payment
  11. Other $66 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $67,669 36 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,956 2 payments
  3. Travel and Lodging $8,614 27 payments
  4. Food and Beverage $4,171 69 payments
  5. Education $2,462 2 payments
  6. Entertainment $32 1 payment
Products named General payments · program years 2019–2025
  1. BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION $32,267 28 payments
  2. AEQUALIS PERFORM $31,682 20 payments
  3. AEQUALIS PERFORM REVERSED $17,542 10 payments
  4. AEQUALIS PERFORM+ $10,649 5 payments
  5. SIMPLICITI $10,400 1 payment
  6. ULTRABUTTON $9,862 3 payments
  7. MICRORAPTOR Sports Med Hip $9,853 6 payments
  8. Q-FIX $9,853 6 payments
  9. MICRORAPTOR Sports Med Hip $9,853 6 payments
  10. HEALICOIL $9,853 6 payments
  11. Other $61,219 100 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 97 billing codes

Paid by Medicare

$139,055

Of which drugs: $5,940

Medicare patients

258

Average age 71

Services billed

2,691

136 women, 122 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 70%
High blood pressure 38%
Ischemic heart disease 17%
Osteoporosis 15%
Cancer 12%
Depression 10%
Atrial fibrillation 8%
Diabetes 6%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 71 762 $552

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

137 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record